The hottest Synthetic Biology Substack posts right now

And their main takeaways
Category
Top Technology Topics
Asimov Press • 303 implied HN points • 16 Mar 26
  1. People overwhelmingly prefer a once‑daily pill, but peptide drugs are ruined by stomach acid and enzymes and are poorly absorbed, so oral GLP‑1s have very low bioavailability and require huge doses that make them expensive.
  2. Scientists solved injectables by changing the peptide and adding a fatty tail so the drug resists breakdown and sticks to albumin, which gives long lasting, effective once‑weekly shots that oral versions still struggle to match.
  3. A promising shortcut is to engineer edible microbes like spirulina to produce and hide GLP‑1 inside cell walls, which could protect the peptide and slash purification costs to make affordable oral pills — though safety, regulation, and public acceptance remain hurdles.
FreakTakes • 26 implied HN points • 13 Mar 26
  1. Flowers by Design: engineer new flower traits across many species to make beautiful, bespoke plants and to uncover general principles of plant development that can translate to food crops.
  2. Biosensor for Anything: build a platform of protein or cell-based sensors plus large datasets and predictive models so we can cheaply and reliably detect many molecules and signals in real-world samples.
  3. Proteins for Pennies: develop a fast, low-cost protein fabricator or "printer" to make any protein for pennies, cutting testing costs and enabling cheaper therapeutics and faster AI-driven design.
Asimov Press • 335 implied HN points • 15 Jan 26
  1. Electroporation has a huge space of possible settings, so getting DNA into non-model microbes is often slow, hit-or-miss, and leaves researchers unsure why experiments fail.
  2. A robotic electroporator that tests many buffers, voltages, waveforms, and plasmid origins—and uses a Bayesian optimizer to choose conditions—can rapidly find working protocols and massively improve transformation efficiency.
  3. Scaling cultivation and transformation for diverse microbes will open up study and engineering of vast, untapped biological diversity, leading to new enzymes, tools, and biotech applications beyond standard lab organisms.
A Biologist's Guide to Life • 29 implied HN points • 26 Jan 26
  1. Living systems are layers of metabolic machines — from genes and proteins to cells, tissues, and organisms — that act like modular, self-replicating components we can study and engineer.
  2. Physical automation (robotic labs, cloud labs) and digital automation (AI-driven biodesign and structure prediction) can make experiments much cheaper, higher-throughput, and faster, enabling far more data and quicker innovation.
  3. Widespread automation is limited by trust, data security, and the need for flexibility as methods evolve, so modular, autonomous lab systems and careful governance are needed to realize its promise.
Viruses Must Die • 44 implied HN points • 19 Dec 25
  1. Ordinary brewer's yeast can be engineered into food-grade vaccines, and the experiments were reportedly doable on a simple household budget.
  2. This method could decentralize vaccine production so people or local microbreweries could make vaccines, potentially bypassing slow licensing and surviving even severe social disruptions.
  3. The target is viruses like polyomaviruses that cause serious illness (for example painful bladder disease in transplant patients), so edible vaccines could prevent a lot of suffering.
Get a weekly roundup of the best Substack posts, by hacker news affinity:
Viruses Must Die • 35 implied HN points • 24 Dec 25
  1. Live brewer’s yeast engineered to make viral proteins can be put into beer and may trigger antibody responses; the authors drank such “vaccine beer” and reported no discernible side effects.
  2. They show you can recreate the necessary plasmids and brew vaccine-containing beer outside a university lab using commercial DNA synthesis and readily available home-lab and brewing supplies, making the approach accessible to homebrewers and small food producers.
  3. They argue food-based vaccines could lower cost and increase access, and that current US law could allow these products to be marketed as GRAS foods so long as no disease-prevention claims are made, while formal medical efficacy testing would remain under regulatory oversight.
Asimov Press • 444 implied HN points • 12 Dec 24
  1. Creating mirrored organisms could be very dangerous. They might spread quickly, infect humans, and even cause extinctions of vulnerable species.
  2. Scientists worry that mirrored cells could escape labs and evade our immune systems. This means they could thrive and multiply without us even knowing.
  3. Most experts believe we should be cautious and avoid creating these mirrored life forms. It's better to discuss the risks now than to face the consequences later.
FreakTakes • 7 implied HN points • 30 Jan 26
  1. The team’s North Star is to make plant engineering like chip design — building synthetic chromosomes and easy, plug-and-play genetic parts so people can design complex, adaptive plant traits.
  2. Progress is blocked by three main technical bottlenecks: transforming and regenerating many plant species, a lack of validated higher-level genetic circuit libraries, and immature hardware to build and iterate large DNA programs.
  3. They fund tool development by mixing contracts and grants, using a high-throughput screening platform to offer screening and co-development services, and aim to grow into an engineering research institute that would need roughly $3–7M per year for about a decade.
The Century of Biology • 453 implied HN points • 28 Jan 24
  1. Industrial biotechnology aims to transition our economy to more sustainable biomanufacturing.
  2. Techno-Economic Analysis (TEA) helps forecast new technology's competitiveness in industrial markets.
  3. Synonym's tool Scaler simplifies TEA for synthetic biologists, potentially changing the financing structure of biomanufacturing.
Not Boring by Packy McCormick • 125 implied HN points • 24 Jan 25
  1. OpenAI's new Stargate Project plans to invest $500 billion over four years in AI infrastructure in the U.S. This could lead to many new jobs and significant economic benefits.
  2. The recent Executive Orders focus on boosting American energy production and supporting the growth of digital assets like cryptocurrency. It's a big move to reinforce economic growth and secure energy independence.
  3. Scientists have created the first fully synthetic eukaryotic genome using yeast. This achievement could lead to making better medicines and biofuels in the future.
De Novo • 110 implied HN points • 12 Dec 24
  1. Synthetic biology can create engineered organisms, which may outcompete natural organisms and harm ecosystems. We need to be careful about the kinds of organisms we create and the possible consequences.
  2. Creating mirror-image organisms could lead to unexpected environmental problems. If these organisms take over, they could cause damage far beyond what we're prepared for.
  3. We should invest in ways to contain engineered organisms and be aware of the risks of releasing them into nature. It's important to proceed cautiously when considering big changes to global ecosystems.
Splitting Infinity • 39 implied HN points • 30 Oct 23
  1. Yeast, especially in precision fermentation, can be genetically modified to produce a wide range of chemicals, biologics, and medicines by augmenting their genes.
  2. The main challenge in precision fermentation is reducing costs, particularly in the purification process where proteins are separated from complex solutions.
  3. Novel techniques like self-cleaving tags and self-aggregating proteins offer promising solutions for purifying proteins in a cost-effective and efficient manner, potentially eliminating the need for expensive purification methods like column chromatography.
Axial • 52 implied HN points • 04 Mar 24
  1. Software and data analytics are being used to transform biomanufacturing, making it easier to control the complex variables involved in producing biological products.
  2. Invert, founded by Martin Permin, integrates with bioreactors and databases to help biomanufacturers manage and optimize their data using AI and analytics.
  3. Invert's platform streamlines bioprocessing by providing tools to plan experiments, monitor processes, analyze results, model scale-up, and collaborate with partners.
Axial • 7 implied HN points • 10 Dec 24
  1. DNA foundation models are helping scientists analyze and understand the complex patterns in genetic data. They can lead to important discoveries in medicine and biology.
  2. Building these models is tough because DNA sequences are long and complicated. Special techniques are needed to process them efficiently and recognize important details.
  3. While these models have great potential, they need to be tested carefully to avoid mistakes. We also need to think about the ethical implications of using them in research and medicine.
The Century of Biology • 27 implied HN points • 04 May 23
  1. The rapid progress of biology is driven by advancements in DNA technology and communication.
  2. The newsletter aims to highlight exciting new research in genetics, genomics, and bioinformatics.
  3. The newsletter does not focus on peer review but instead aims to share exciting discoveries and findings.
Mark Smith’s Newsletter • 0 implied HN points • 15 Jul 23
  1. A new computation paradigm of synthetic biology is gaining traction, transforming atoms to DNA sequences and allowing the growth of materials without complicated supply chains.
  2. Podcasts are changing how people interact and could spark a new Age of Enlightenment.
  3. Hollywood actors are on strike, while Elon Musk's Tesla is entering the UK energy market and launching a new xAI company.